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ABSTRACT 
 
Background: Prior epidemiologic studies predicted a rapid rise in herbal medicine-related acute liver injury (HILI) and liver 
transplantation (LT) as trading of traditional herbal medicine drugs is expanded. HILI is the leading cause of liver 
transplantation in the world. The indication for LT was defined as acute liver failure (ALF) with the factor V (FV) level 
below 35%. Objective: To explore the possible impact of herbal medicine-related to the liver failure on the laboratory 
parameters and to determine if simple laboratory values play a role in determining lower FV levels. Materials and methods: 
Totally, 38 HILI cases who were admitted to a tertiary care hospital between May 2016 and May 2018 were scanned, 
retrospectively. Need for LT was assessed by the determination of FV levels. Results: The mean age of participants was 
37±13 years where 27 (71%) were female while the rest were male and 81% of the total populations were farmers. Total 
78% patients were reportedly consuming herbal medicine pills, and 22% reported consuming traditional Turkish herbs. 
Among 38 cases with HILI in critical care, 2 (5.2%) have died, 3 (7.8%) underwent LT and 33 (87%) were recovered and 
discharged. Results of 38 patients with available data also showed that factor V levels were positively correlated with the 
hemoglobin and platelet levels (p<0.05) and negatively correlated with prothrombin time (p<0.05). Conclusion: These 
findings suggest that detecting anemia and thrombocytopenia could be an important, economically feasible strategy for 
improving outcomes in HILI. 
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cute liver failure (ALF) is the combination of 
acute liver injury, hepatic encephalopathy and 
elevated prothrombin time in a person with no 
prior history of liver disease. It is also referred to as 
fulminant hepatic failure [1]. A wide scale of causes can 
result in ALF including drugs, herbal products, toxins, 
viral hepatitis, varicella zoster virus (VZV), herpes 
simplex virus (HSV), autoimmune hepatitis, mushroom 
poisoning (Amanita phalloides), Reye’s syndrome, acute 
fatty liver of pregnancy, Budd-Chiari syndrome, 
hypoperfusion, HELLP syndrome, heatstroke, Wilson 
disease and  tumoral infiltration etc [2.3]. 
 Patients with ALF can apply to the hospital with 
nonspecific symptoms but then jaundice, encephalopathy, 
coagulopathy, metabolic abnormalities, renal dysfunction, 
ascites, sepsis, lung injury, hemodynamic instability, are 
developed by the time [4]. Management of ALF includes 
intensive care support, treatment of specific etiology if it is 
known, and early determination of the candidates for liver 
transplantation (LT). Prognostic scoring systems mostly 
used in ALF are King’s College criteria, Clichy-Villejuif 
criteria and Model for end-stage liver disease (MELD). 
These systems have been used to assess the severity of 
ALF and to identify candidates of transplantation [5].  
 Herbal medicines have gained popularity among 
individuals worldwide because it is considered to be 
natural and safe. In contrast to this idea, herbs may cause 
adverse reactions of variable severity and numerous 
A 
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organs; specifically, the liver can be affected [6-8]. 
Nonscientific usage of herbal products can accompany 
ALF and which may lead to the need of transplantation. 
The aim of this study is to evaluate the correlation of 
hematologic parameters in herb induced liver injury (HILI) 
and to make some suggestions for their prognostic value. 
METHODS  
This retrospective study was conducted in a tertiary care 
hospital for a period of 2 years i.e. from May 2016 to May 
2018. The study was conducted after getting the ethics 
committee approval and after getting consent from the 
patients. Total 38 cases, who were admitted with a 
diagnosis of herb induced ALF, were included in this 
study. Their demographic and clinical data were collected 
by reviewing electronic medical records of the hospital.  
Those patients were included in the study who were 
reportedly having hepatotoxicity due to herbs, herbal drugs 
and herbal dietary supplements. Patients with acute or 
chronic viral hepatitis, metabolic liver diseases, Wilson's 
disease, and autoimmune hepatitis were excluded from the 
study. In addition, patients with malignancies including 
hepatocellular carcinoma, were also excluded..  
Need for LT was assessed by the determination of 
Factor V levels. Descriptive statistics, Chi-squared and t-
tests were used for analysis. Multi-variable logistic 
regression was used to identify laboratory parameters 
associated with FV levels. SPSS program and Pearson 
correlation were used to investigate the relation between 
the biochemical parameters. 
RESULTS 
Out of the total 38 patients, 27 (71%) were female and 11 
(29%) were male. Mean age of the participants was 37±13 
years. The occupational data shows that among the study 
participants, 81% were farmers. A total of 78% of patients 
were reported of consuming herbal medicine pills; and 
22% reported consuming traditional Turkish herbs. Among 
38 cases with HM- related ALF in critical care, 2 (5.2%) 
participants died, 3 (7.8%) underwent LT and 33 (87%) 
recovered during the study and were discharged.  
The descriptive statistics of the patients and the 
comparison in the result groups are shown in Table 1. 
Results of the 38 patients with available data shows that 
Factor V levels were positively correlated with 
hemoglobin and platelet levels (p<0.05) and negatively 
correlated with prothrombin time (p<0.05). Factor VIII 
levels were strongly and positively correlated with 
prothrombin time (p<0.01), and positively correlated with 
total bilirubin levels (p<0.05), while it was negatively 
correlated with platelet levels (p<0.05). All the patients 
who underwent LT or died, had a Factor V levels below 
than 30% compared to discharged counterparts (p<0.005).   
Table 1: Descriptive statistics and comparison results 
by groups 
 
Lab Testing 
Parameters 
N Mean 
Std. 
Deviat
ion 
Minimu
m 
Maximu
m 
Aspartate 
transaminase 
IU/ml 
38 137.60 257.78 15.0 1240.0 
Alanine 
transaminase 
IU/ml 
38 171.52 255.73 7.0 1172.0 
Glucose (mg/dl) 38 108.26 116.98 65.0 800.0 
Alkaline 
phosphatase 
IU/ml 
38 165.47 230.13 47.0 1408.0 
Gamma-
glutamyltransfer
ase IU/ml 
38 136.32 222.88 0.9 873.0 
Albumin (mg/dl) 38 3.51 0.97 0.25 4.90 
Globulin (mg/dl) 31 3.21 0.84 1.90 5.20 
Total Bilirubin  
(mg/dl) 
38 3.22 5.50 0.32 24.12 
Direct Bilirubin  
(mg/dl) 
36 2.56 4.75 0.04 20.0 
Leukocyte 
count(cells×10
3
/
mm
3
) 
38 7.13 2.48 2.9 13.5 
Neutrophils  
(cells×10
3
/mm
3
) 
38 4.30 2.16 0.2 11.9 
Hemoglobin  
(gm/dl) 
38 12.97 2.41 6.4 16.8 
Platelet Count 
(cells×10
3
/mm
3
) 
38 199.55 83.05 27.0 393.0 
Factor V 37 61.43 33.03 15.0 191.0 
Factor VIII 18 77.94 74.74 14.0 300.0 
PH 20 7.40 0.05 7.24 7.55 
HCO3 20 21.22 3.25 12.0 27.0 
Prothombin time 36 15.97 4.39 11.7 28.6 
DISCUSSION 
While there may be a number of possible explanations for 
the increase in HILI, our data highlight urgent need for the 
simple diagnostic tools to predict ALF. The diagnosis of 
drug-induced liver injury (DILI) relies on compatible 
history, liver function tests and exclusion of other causes. 
DILI is attributed to any drug or herbal and dietary 
supplement within 6 months of liver injury onset [9]. Liver 
injury associated with the consumption of herbal 
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medicines is defined as HILI, which is almost similar to 
those of DILI [10]. 
Most of the cases of ALF have an identifiable etiology. 
In the US reports, approximately 12% of cases were 
considered indeterminate ALF (IND-ALF) which has 
mostly caused by occult viruses or toxins. All the patients 
were presented with hepatocellular injury but were 
misdiagnosed usually due to lack of hepatitis E virus 
(HEV) Ig M testing at the time of liver injury onset. These 
findings indicate that exclusion of acute HEV requires 
anti-HEV Ig M testing in patients with suspected HILI 
[11]. In compared to this finding, our study had nil patients 
who were found to be positive in the test for acute HEV 
infection. 
In a study by Teschke R et al [12], all the patients 
presented with hepatocellular injury but were 
misdiagnosed usually due to lack of hepatitis C virus 
(HCV) RNA testing, at the time of liver injury onset. 
These findings also indicate that exclusion of acute HCV 
requires HCV RNA testing in patients with suspected DILI 
[12]. In the current study, all the patients were tested 
negative for HCV- RNA with PCR technique. Anti-
tuberculosis drugs are the most common cause of DILI and 
the cases of drug-induced ALF are more common in 
middle and low income countries. Although, in a study by 
Cao J et al [13], more subjects developed DILI in the study 
population, due to extensive usage of the anti-tuberculosis 
drugs. In our study, there were no patients with DILI amid 
study population.  
Recent reports have suggested that the incidence of 
DILI from herbal and dietary supplement has increased in 
the past years. In addition, women and persons older than 
60 years are more likely to present with HILI. 
Furthermore, Szantova M et al [14] suggested that sex 
differences in absorption, distribution, metabolism and 
excretion (ADME) should be investigated to understand 
the increased pre-disposition of HILI in women. In the 
current study, nearly 75% of the study subjects were 
women and our findings were in line with the other 
studies.  
Clichy Villejuif (CV) criteria is one of the most widely 
used tools worldwide to determine a prognosis for ALF or 
FH. The CV criteria is mainly used in Europe, and they 
include grade 3 or 4 hepatic encephalopathy and factor V 
levels less than 20% in patients below than 30 years of age 
and less than 30% in patients above than 30 years of age 
[15]. Our data strongly support the routine assessment of 
factor V-related hematologic parameters to enhance the 
care of patients awaiting liver transplantation. In addition, 
our findings also uncover anemia and thrombocytopenia as 
simple markers for predicting lower factor V levels and 
open perspectives for novel liver transplantation strategies 
based on the simple field tests. The limitation to this study 
was that the results may not generalized entire population 
of the region with ALF due to small sample size. 
CONCLUSION 
In this study, we assessed the simple hematologic 
parameters in HILI patients. Our findings point to a critical 
role of hemoglobin and platelet levels in HILI 
development in rural areas of Asia. Better and simpler 
methods to identify ALF, will diminish the high-cost tests 
for developing countries. It may be also concluded that the 
performance of the CV criteria could be improved by the 
integration of hemoglobin and platelet levels into the 
prediction of outcomes for HILI. 
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